Andrew Brackin, Partner at Gradient Ventures, on AI Startups & HealthTech

Andrew Brackin is a Partner at Gradient Ventures. ~~~~~This episode is brought to you by Verivend. If you’re a GP or LP looking to simplify the capital raising and deployment process, Verivend is here to help. Trusted by over 800 funds and managing more than $2 billion in transactions, Verivend offers a secure, streamlined payments platform designed specifically for private capital markets. Say goodbye to manual reconciliation and repeated follow-ups - raise and deploy capital faster and with greater transparency. Ready to make your fund operations smoother? Visit https://bit.ly/3GrB4Qj and see how easy it can be.~~~~~Prior to Gradient, Andrew co-founded Vial, a tech-enabled clinical trial platform that raised over $100M in venture capital from top-tier firms. Prior to Vial, he was part of the founding team and the Head of Growth at Newfront (YC W18), an AI-powered commercial insurance brokerage valued at $2.2BN, insuring numerous Fortune 500 companies. His career began at Jobr, a mobile job search business that Monster.com acquired in 2016. Andrew was a 2013 recipient of the Thiel Fellowship. Outside of work, he loves reading about global affairs, working out at Barry’s Bootcamp, and enjoying live music.Topics: Lessons from raising $100M+ and building in a complex, regulated industrySectors that are overhyped vs. undervalued in today's marketPredictions for the next wave of healthcare innovation#StartupLeadership #HealthTech #VentureCapital #ThielFellowship #AIinInsurance

There are no comments yet.

Please log in to write the first comment.